Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AERI

Aerie Pharmaceuticals (AERI) Stock Price, News & Analysis

Aerie Pharmaceuticals logo

About Aerie Pharmaceuticals Stock (NASDAQ:AERI)

Advanced Chart

Key Stats

Today's Range
$15.25
$15.25
50-Day Range
$15.18
$15.25
52-Week Range
$4.81
$15.37
Volume
600 shs
Average Volume
974,748 shs
Market Capitalization
$753.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AERI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aerie Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

AERI Stock News Headlines

Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.
20 Countries With Worst Vision Problems
See More Headlines

AERI Stock Analysis - Frequently Asked Questions

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) released its quarterly earnings data on Thursday, November, 4th. The company reported ($0.72) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.62) by $0.10. The business had revenue of $29.31 million for the quarter, compared to the consensus estimate of $29.13 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aerie Pharmaceuticals investors own include Canopy Growth (CGC), Nicox (NICXF), Bristol Myers Squibb (BMY), Meta Platforms (META), NVIDIA (NVDA), Pfizer (PFE) and Melinta Therapeutics (MLNT).

Company Calendar

Last Earnings
11/04/2021
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:AERI
CIK
1337553
Employees
376
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.77)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$74.81 million
Net Margins
-17.09%
Pretax Margin
-16.47%
Return on Equity
N/A
Return on Assets
-2.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.27
Quick Ratio
1.92

Sales & Book Value

Annual Sales
$194.13 million
Price / Sales
3.88
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.32) per share
Price / Book
-4.59

Miscellaneous

Outstanding Shares
49,417,000
Free Float
47,223,000
Market Cap
$753.61 million
Optionable
Optionable
Beta
-0.06

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:AERI) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners